2-[5-[(4-fluorophenyl)methyl]thiazol-2-yl]-3-hydroxy-7-(4-isopropylpiperazin-1-yl)-9-(3-methyl-2-oxo-imidazolidin-1-yl)pyrido[1,2-a]pyrimidin-4-one | 1251462-40-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 2-[5-[(4-fluorophenyl)methyl]thiazol-2-yl]-3-hydroxy-7-(4-isopropylpiperazin-1-yl)-9-(3-methyl-2-oxo-imidazolidin-1-yl)pyrido[1,2-a]pyrimidin-4-one
• 英文别名: 2-[5-[(4-Fluorophenyl)methyl]thiazol-2-yl]-3-hydroxy-7-(4-isopropylpiperazin-1-yl)-9-(3-methyl-2-oxo-imidazolidin-1-yl)pyrido[1,2-a]pyrimidin-4-one；2-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-3-hydroxy-9-(3-methyl-2-oxoimidazolidin-1-yl)-7-(4-propan-2-ylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one
• CAS: 1251462-40-4
• 化学式: C₂₉H₃₂FN₇O₃S
• 分子量: 577.683
• InChiKey: SEIPQVGCHKOTQF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  41
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  124
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  3-(benzyloxy)-2-(5-(4-fluorobenzyl)thiazol-2-yl)-7-(4-isopropylpiperazin-1-yl)-9-(3-methyl-2-oxoimidazolidin-1-yl)-4H-pyrido[1,2-a]pyrimidin-4-one 在 三氟乙酸 作用下， 反应 3.0h， 生成 2-[5-[(4-fluorophenyl)methyl]thiazol-2-yl]-3-hydroxy-7-(4-isopropylpiperazin-1-yl)-9-(3-methyl-2-oxo-imidazolidin-1-yl)pyrido[1,2-a]pyrimidin-4-one
  参考文献：
  名称：

  Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses

  摘要：

  A series of novel HIV integrase inhibitors active against rategravir resistant strains are reported. Initial SAR studies revealed that activities against wild-type virus were successfully maintained at single digit nanomolar level with a wide range of substitutions. However, inclusion of nitrogen-based cyclic substitutions was crucial for achieving potency against mutant viruses. Several compounds with excellent activities against wild-type virus as well as against the viruses with the mutations Q148H/G140S or N155H/E92Q were reported. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.07.041

文献信息

• [EN] COMPOUNDS FOR TREATMENT OF FELINE LEUKEMIA IN FELIDAE<br/>[FR] COMPOSÉS DESTINÉS AU TRAITEMENT DE LA LEUCÉMIE FÉLINE CHEZ LES FÉLIDÉS
  申请人：UNIV ZUERICH

  公开号：WO2012095388A2

  公开（公告）日：2012-07-19

  The invention provides for inhibitors of HIV integrase, particularly raltegravir, for the treatment of FeLV in felidae, particularly in house cats.